Houston-based biotechnology firm Cellenkos Inc. raised growth funding to develop therapies to treat autoimmune and inflammatory disorders.
News
- Cellenkos raises $15M Series A for platform targeting treatments for autoimmune ...
- Jason Kidd and late game free-throw scenarios are a rollercoaster ride | Editorials 24
A situation late in the game between the Dallas Mavericks and San Antonio Spurs would have given fans of the Milwaukee Bucks a blast from the past ...
- NaturalShrimp Appoints Aquaculture Veteran Rafael Zelaya as Vice President of Production ...
DALLAS, TX, Nov. 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Company that has ...
- The ardent virus allows San Antonio researchers to track how COVID-19 spreads in real ...
“These fluorescent viruses make it easy to identify whether a cell is infected,” said Dr. Luis Martinez Sobrid, a Texas biomed virologist. The ardent ...
- Puma Biotechnology, Inc. (PBYI) CEO Alan Auerbach on Q3 2021 Results - Earnings Call ...
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q3 2021 Earnings Conference Call November 4, 2021 4:30 PM ETCompany ParticipantsMariann Ohanesian - Senior ...